Scientific publishing needs to change. In a new preprint, HHMI President Erin O'Shea and Bodo Stern argue that the incentives are misaligned. Researchers should be evaluated on what they choose to share, not what journals select. I’m proud that @hhmi_science is leading the way. Read the preprint here: https://t.co/CV1iiwgIvY
It’s incredible how ChatGPT gently reminds me of my postdoc clock and gently nudges me to apply for faculty while depicting my time at the bench.
Prompt: “make a caricature of me and my work based on all the information you have about me”
🚨 “Controversial Refereeing Casts Shadow Over the Match”
In a dramatic turn, a player who should have been sent off for a second yellow remained on the field and scored just minutes later, igniting heated debate. Meanwhile, in a similar situation, a Galatasaray player received a second yellow and was sent off, raising serious questions about the consistency of refereeing decisions. This apparent double standard has made the match a focal point for scrutiny and criticism in European football circles.”
This week’s #UTSWCancerBio WIP: Mark Mannino (Morrison Lab) Type I Interferons & Metastatic Potential in Melanoma
Exploring how IFN signaling heterogeneity shapes melanoma metastasis and immune evasion through PD-L1 & CD47 pathways. #CancerResearch#Immunology#Melanoma
New work from our lab describing a role for mitochondrial glutathione in breast cancer metastasis @nicoledelgaudio @RockefellerUniv https://t.co/4KF3xqZSFC
We are hiring! After the publication of our last paper, our lab has openings for #postdoc fellows in projects looking at the interactions between tumor metabolism and immunology. Direct inquiries to [email protected]. Please RT! (1/2)
ONLINE NOW @CD_AACR: CRI scientists link hematopoietic cell transplant deaths to beta-blocker use. Research from @SJMorrison_, @StephenChung16 & @AshKishtagari shows nerve signaling needed for regeneration may be impaired by meds. #relentlessdiscovery https://t.co/03QwHl0x3Z